ilmscore | Prediction Details
"this is still a pre-revenue company with its first clinical patient not expected until next year and years outside meaningful revenues"
By Let's Talk Money! with Joseph Hogue, CFA | June 14, 2024 | Pending
From video
7 AI Stocks to Buy Revolutionizing Healthcare 00:06:47 - 00:06:53
Interpreted Prediction
Vicarious Surgical (RBOT) is not expected to have its first clinical patient until 2025 and meaningful revenues for years after that.

Prediction Details

Ticker
RBOT
Initial Price
8.12 USD

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.